Evidence map›Paper›PMID 39484396›Full record

ArticlebioRxiv : the preprint server for biology2024

A Transcriptional Signature of Induced Neurons Differentiates Virologically Suppressed People Living With HIV from People Without HIV.

Philipp N Ostermann, Youjun Wu, Scott A Bowler, Mohammad Adnan Siddiqui, Alberto Herrera, Mega Sidharta, Kiran Ramnarine, Samuel Martínez-Meza, Leslie Ann St Bernard, Douglas F Nixon and 5 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors.

Philipp N OstermannDivision of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, New York, NY 10065, USA.
Youjun WuThe SKI Stem Cell Research Facility, The Center for Stem Cell Biology and Developmental Biology Program, Sloan Kettering Institute, New York, NY 10065, USA.
Scott A BowlerDivision of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, New York, NY 10065, USA.
Mohammad Adnan SiddiquiAaron Diamond AIDS Research Center, Columbia University Vagelos College of Physicians and Surgeons, New York, NY. 10032, USA.
Alberto HerreraDivision of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, New York, NY 10065, USA.
Mega SidhartaThe SKI Stem Cell Research Facility, The Center for Stem Cell Biology and Developmental Biology Program, Sloan Kettering Institute, New York, NY 10065, USA.
Kiran RamnarineThe SKI Stem Cell Research Facility, The Center for Stem Cell Biology and Developmental Biology Program, Sloan Kettering Institute, New York, NY 10065, USA.
Samuel Martínez-MezaDivision of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, New York, NY 10065, USA.
Leslie Ann St BernardDivision of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, New York, NY 10065, USA.
Douglas F NixonDivision of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, New York, NY 10065, USA.
R Brad JonesDivision of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, New York, NY 10065, USA.
Masahiro YamashitaAaron Diamond AIDS Research Center, Columbia University Vagelos College of Physicians and Surgeons, New York, NY. 10032, USA.
Lishomwa C NdhlovuDivision of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, New York, NY 10065, USA.ORCID 0000-0001-5427-4187
Ting ZhouThe SKI Stem Cell Research Facility, The Center for Stem Cell Biology and Developmental Biology Program, Sloan Kettering Institute, New York, NY 10065, USA.
Teresa H EveringDivision of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, New York, NY 10065, USA.

Funding

HOPE - HIV Obstruction by Programmed EpigeneticsUM1AI164559 · NIAID · J. DAVID GLADSTONE INSTITUTES · PI Lishomwa C Ndhlovu, Melanie Maria Ott · 2021 to 2026
$32.2M
Elucidating single cell changes in neurogenic brain regions during HIV and cannabinoid exposureU01DA058527 · NIDA · WEILL MEDICAL COLL OF CORNELL UNIV · PI Michael Jay Corley, Lishomwa C Ndhlovu · 2023 to 2026
$9.4M
Impact of IL-15 immunotherapy on tissue-specific CD8 T cells to reduce the CNS HIV reservoir seeding and persistenceR01MH130197 · NIMH · OREGON HEALTH & SCIENCE UNIVERSITY · PI Lishomwa C Ndhlovu, Afamefuna Okoye · 2022 to 2026
$5.1M
Development of Brain Organoids to Study the Impact of HIV-1, Drugs of Abuseand Aging on Cognitive ImpairmentR01DA052027 · NIDA · WEILL MEDICAL COLL OF CORNELL UNIV · PI NDHLOVU, LISHOMWA C, NIXON, DOUGLAS F · 2020 to 2024
$3.7M
Host Glycomic Modulation of HIV-associated Neuro-inflammation During Viral SuppressionR01NS117458 · NINDS · WISTAR INSTITUTE · PI ABDEL MOHSEN, MOHAMED, NDHLOVU, LISHOMWA C · 2020 to 2023
$3.4M
The Role of Transposable Elements in Healthy Aging and in Alzheimer's DiseaseR56AG078970 · NIA · WEILL MEDICAL COLL OF CORNELL UNIV · PI NIXON, DOUGLAS F · 2022 to 2022
$1.4M
A Precision Medicine Approach to Investigating the Molecular Impact of Age and Neurocognitive Impairment in People Living with HIV (PLWH)R21NS126094 · NINDS · WEILL MEDICAL COLL OF CORNELL UNIV · PI EVERING, TERESA · 2021 to 2021
$557k
Single-Cell Analysis of HIV ReplicationR56AI125128 · NIAID · AARON DIAMOND AIDS RESEARCH CENTER · PI YAMASHITA, MASAHIRO · 2017 to 2017
$495k
Leveraging Directly Reprogrammed Human Neurons to Investigate the Molecular Impact of Age and Distinct Antiretroviral Therapies in Individuals Living with HIV-1R21AG071433 · NIA · WEILL MEDICAL COLL OF CORNELL UNIV · PI EVERING, TERESA · 2021 to 2022
$489k
NIAID NIH HHS R56 AI125128NIAID NIH HHS UM1 AI164559NIA NIH HHS R21 AG071433NIA NIH HHS R56 AG078970NIDA NIH HHS R01 DA052027NIDA NIH HHS U01 DA058527NIMH NIH HHS R01 MH130197NINDS NIH HHS R01 NS117458NINDS NIH HHS R21 NS126094
6 · The paper itself

Abstract

Neurocognitive impairment is a prevalent and important co-morbidity in virologically suppressed people living with HIV (PLWH), yet the underlying mechanisms remain elusive and treatments lacking. Here, we explored for the first time, use of participant-derived directly induced neurons (iNs) to model neuronal biology and injury in PLWH. iNs retain age- and disease-related features of the donors, providing unique opportunities to reveal novel aspects of neurological disorders. We obtained primary dermal fibroblasts from six virologically suppressed PLWH (range: 27 - 64 years, median: 53); 83% Male; 50% White) and seven matched people without HIV (PWOH) (range: 27 - 66, median: 55); 71% Male; 57% White). iNs were generated using transcription factors NGN2 and ASCL1, and validated by immunocytochemistry and single-cell-RNAseq. Transcriptomic analysis using bulk-RNAseq identified 29 significantly differentially expressed genes between iNs from PLWH and PWOH. Of these, 16 genes were downregulated and 13 upregulated in PLWH iNs. Protein-protein interaction network mapping indicates that iNs from PLWH exhibit differences in extracellular matrix organization and synaptic transmission.

Indexed as

agingdirectly converted neuronsHANDHIVHIV-related neurocognitive impairmentIFI27induced neuronsiNsneurodegenerative diseasetransdifferentiation

Identifiers

PMID39484396
PMCPMC11526917

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.